Review evaluates clinical evidence for particle therapy's efficacy in various tumors, indicating its expanding accessibility.
Particle therapy offers highly precise treatment, reducing damage of surrounding organs while delivering dose to the target areas. The improved therapeutic ratio is largely attributed to the Bragg curve, which demonstrates steep dose fall-off. Although historically pediatric tumors had the clearest benefit, the application of particle therapy has expanded to adult patients of all disease sites, including tumors of the head and neck, central nervous system, thorax, breast, gastrointestinal system, and genitourinary system. As emerging trials provide increasing evidence for the utilization of particle therapy, treatment is becoming more accessible. In addition, radiation technology continues to evolve, and techniques including intensity-modulated proton therapy and adaptive proton therapy are being implemented. We review the evolution of particle therapy, the current clinical evidence supporting its use, and practical considerations.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: